Additionally, the methylation profile of the SOX30 promoter region has already been identified in chronic myeloid leukemia (CML) patients, but the biological role of this mechanism remains unrevealed. Here, SOX30 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.